CIGARETTE SALES IN THE U.S. CONTINUE HISTORIC DECLINE INTO THE FIRST QUARTER OF 2019 Juul Labs Altria Stock Sinks Amid Reports of Juul Ban After two costly vaping acquisitions (JUUL & NJOY), Altria shares are down 3% following the first ever authorization of non tobacco, non menthol flavored vapes. This once again raises questions around management's capital allocation in The FDA Just Approved Juul's E Cigarettes. Does That Make Altria Stock a Buy Here? Altria Faces Juul Antitrust Trials As Valuation Discount Draws Attention The U.S. stock market is falling below its all time high following mixed profit reports from Tesla and other big companies and as crude oil prices rise.